Columbia, MD — January 9th 2007 — Expo Technologies announced today that it has acquired SpectrAlliance Inc., St. Louis, MO, for an undisclosed sum. “This is consistent with our mission to become the PAT implementation partner of choice for the pharmaceutical community”, Peter Bennett, General Manager, explained; “We possess expertise in PAT measurement device hardware, applications, plant project management and now measurement and chemometric software for the Pharmaceutical Industry”.

President and founder of SpectrAlliance, Inc., Susan Bragg, Ph. D. further commented on the formalization of the partnership; “Expo Technologies and SpectrAlliance have worked closely together for a number of years. SpectrAlliance provides PAT focused software tools and systems to both Expo and the PAT community. This partnership strengthens our ability to provide the most comprehensive PAT solutions to our customers.”

NovaPAC and NovaMath, SpectrAlliance’s flagship software products, were developed specifically to address the compliance, IT, and real time analytics requirements of the pharmaceutical manufacturing community, including 21CFR11.

Paul Davies, Vice President of Marketing, further added “this acquisition completes the PAT puzzle. Expo now has competence ranging from the sample interface, through practical plant implementation, to spectroscopic analytics, data management and process control. We are now capable of offering a more complete solution, across multiple technologies and disciplines.”

Expo Technologies’ mission is to become the PAT implementation partner of choice for the pharmaceutical industry through rigorous design and manufacture of “Unit Operation Specific” measurement devices utilizing a Project Management Approach. Expo Technologies is dedicated to the business of Pharmaceutical PAT Implementation.